A bit of positive PR for Alchemia including a decent size picture of CEO Thomas Liquard with the article. He was the only biotech company representative quoted in the story. The rest of the commentary was from analysts, or funded managers and focused on a portfolio approach to investing in biotech. Scott Power did however have 4 picks in the sector in different categories, including Alchemia
A bit of positive PR for Alchemia including a decent size...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable